StockData
Boston Scientific Corp logo

Boston Scientific Corp (BSX) shareholders

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3048% below fair value
$43.03−0.66 (-1.51%)

Close on Nov 17, 2026Market cap $62.36BP/E 17.4Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
92.1%
1.34B of 1.45B shares
Institutional holders
1,474
147 new, 326 sold out
Net institutional buying
8M
In Q2 2026
Insider trades, 12 months
10 buys · 3 sales
Net sold $6.76M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.113,006,6717.60%13G (passive) amendmentMar 31, 2025
Vanguard Capital Management111,127,2057.47%13G (passive)Mar 31, 2026
FMR LLC
Joint filing with Abigail P. Johnson (7.50%)
110,320,9387.50%13G (passive) amendmentJun 30, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of BSXValueChange% of portfolio
BlackRock, Inc.129,680,9168.95%$5.53B−2,141,1210.08%
Vanguard Capital Management LLC97,087,5536.70%$4.14B+675,9850.09%
State Street Corp70,111,1964.84%$2.99B+2,124,3490.09%
Primecap Management Co/Ca/50,520,9143.49%$2.16B+17,991,1401.28%
FMR LLC45,702,8453.15%$1.95B−28,523,5500.08%
Geode Capital Management, LLC33,440,1022.31%$1.42B+154,3450.08%
Vanguard Portfolio Management LLC29,792,7942.06%$1.27B−3,4170.06%
D. E. Shaw & Co., Inc.25,457,4091.76%$1.09B+1,145,0570.52%
Massachusetts Financial Services Co /Ma/24,859,1911.72%$1.50B+13,862,6190.48%
JPMorgan Chase & Co23,907,8381.65%$1.04B−9,442,3190.06%
Arrowstreet Capital, Limited Partnership23,293,9131.61%$994.18M+9,402,2450.44%
Norges Bank21,170,0291.46%$903.54MNew0.09%
Two Sigma Investments, LP19,359,0231.34%$826.24M+9,947,7920.60%
Morgan Stanley18,947,1471.31%$808.66M−3,319,5170.04%
Jupiter Topco LLC18,822,8531.30%$803.36MNew0.33%
Bollard Group LLC18,420,7201.27%$786.20M−111,45323.93%
Goldman Sachs Group Inc16,954,3421.17%$723.61M−1,937,2820.06%
Capital World Investors16,812,2571.16%$717.60M+1,502,5190.08%
UBS Group AG16,352,4201.13%$697.92M+1,527,7580.09%
Wellington Management Group Llp15,301,8281.06%$653.08M−3,531,5780.11%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20261,4741.34B92.1%147 / 587614 / 326206M198M
Q1 20261,6791.34B92.8%196 / 677637 / 280313M197M
Q4 20251,7901.37B94.6%235 / 668692 / 129130M129M
Q3 20251,7161.38B95.1%179 / 768559 / 131125M107M
Q2 20251,6941.36B93.9%156 / 754552 / 9191M78M
Q1 20251,6481.35B93.2%231 / 668555 / 7488M68M
Q4 20241,5191.34B92.7%220 / 618492 / 8479M83M
Q3 20241,4021.35B93.2%166 / 565478 / 76179M59M
Q2 20241,3231.36B93.7%171 / 554419 / 5374M98M
Q1 20241,2261.40B96.3%158 / 441452 / 7090M68M
Q4 20231,1511.39B95.7%178 / 442377 / 68122M73M
Q3 20231,0591.34B92.4%99 / 440353 / 9582M63M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

978 funds held BSX in Q2 2026, 40% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of BSXValue% of fundAs of
Vanguard Total Stock Market Index Fund47,181,2843.26%$2.01B0.09%Jun 30, 2026
Vanguard 500 Index Fund38,518,7882.66%$1.64B0.10%Jun 30, 2026
Vanguard Primecap Fund30,831,0392.13%$1.32B1.37%Jun 30, 2026
iShares Core S&P 500 ETF20,445,3451.41%$872.61M0.10%Jun 30, 2026
Fidelity 500 Index Fund18,978,2371.31%$916.84M0.11%May 31, 2026
Growth Fund of America13,027,8390.90%$629.37M0.17%May 31, 2026
Vanguard Health Care Fund12,474,1120.86%$582.92M1.53%Jul 31, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF10,500,6470.72%$448.17M1.10%Jun 30, 2026
Vanguard Growth Index Fund9,210,3390.64%$393.10M0.10%Jun 30, 2026
Vanguard Capital Opportunity Fund8,820,2060.61%$376.45M1.15%Jun 30, 2026
Vanguard Institutional Index Fund8,069,0420.56%$344.39M0.10%Jun 30, 2026
Vanguard Value Index Fund7,086,7570.49%$302.46M0.12%Jun 30, 2026
AMCAP Fund6,913,1840.48%$333.98M0.34%May 31, 2026
Janus Henderson Enterprise Fund6,658,9700.46%$284.20M1.27%Jun 30, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund6,238,6510.43%$301.39M0.12%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Michael F. MahoneyChairman, President & CEO, Director1,864,3770.13%Nov 6, 2026
Miriam O'SullivanSVP, Chief HR Officer21,2960.00%Nov 3, 2026
Padraig Andrew O'ConnorEVP, Global Operations7,8920.00%Sep 3, 2026
Emily WoodworthSVP, Global Controller and CAO6,0530.00%Aug 12, 2026
Jonathan MonsonEVP and CFO48,9710.00%Aug 11, 2026
Joseph Michael FitzgeraldEVP & Group Pres, Cardiology283,3390.02%Aug 3, 2026
Arthur C. ButcherEVP& Grp Pres, MedSurg & APAC78,1220.01%May 4, 2026
Vance R. BrownEVP, GC and Corp. Secretary55,1340.00%Feb 18, 2026
John Bradley SorensonEVP, Global Operations18,7050.00%May 6, 2025
Jeffrey B. MirvissEVP&Pres, Periph Intervent50,7660.00%Feb 25, 2025
Daniel J. BrennanEVP and CFO283,6580.02%Feb 19, 2025
Wendy CarruthersEVP, Human Resources29,3080.00%Dec 4, 2024
Susan E. MoranoDirector13,7840.00%Aug 26, 2026
David C. HabigerDirector17,1600.00%Aug 7, 2026
Edward J. LudwigDirector30,3590.00%Aug 3, 2026
Cheryl PegusDirector1,7700.00%May 21, 2026
Christophe Pierre WeberDirector2,6460.00%May 11, 2026
David S. WichmannDirector45,3820.00%May 11, 2026
Cathy R. SmithDirector1410.00%May 11, 2026
Jessica L. MegaDirector12,0350.00%May 11, 2026
Ellen M. ZaneDirector27,9340.00%May 11, 2026
Yoshiaki FujimoriDirector2,0810.00%Jul 30, 2025
John E. SununuDirector54,7230.00%May 9, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Michael F. Mahoney
Chairman, President & CEO, Director
Nov 4, 2026Gift+102,249––252,241
Michael F. Mahoney
Chairman, President & CEO, Director
Nov 4, 2026Gift+149,992––149,992
Miriam O'Sullivan
SVP, Chief HR Officer
Nov 1, 2026Tax withholding−1,872$41.98$78.59K19,565
Miriam O'Sullivan
SVP, Chief HR Officer
Nov 1, 2026Option exercise+3,871––21,437
Padraig Andrew O'Connor
EVP, Global Operations
Sep 2, 2026Tax withholding−567$48.37$27.43K7,892
Padraig Andrew O'Connor
EVP, Global Operations
Sep 2, 2026Option exercise+1,171––8,459
Susan E. Morano
Director
Aug 25, 2026Buy+2,040$49.22$100.41K13,784
Emily Woodworth
SVP, Global Controller and CAO
Aug 11, 2026Discretionary+2,930$51.19$149.99K2,930
Jonathan Monson
EVP and CFO
Aug 10, 2026Discretionary+9,908$50.46$499.96K9,908
David C. Habiger
Director
Aug 5, 2026Buy+2,100$47.59$99.94K17,160
David C. Habiger
Director
Aug 4, 2026Buy+140$48.59$6.80K15,060
Michael F. Mahoney
Chairman, President & CEO, Director
Aug 3, 2026Discretionary+22,119$48.43$1.07M22,119
Michael F. Mahoney
Chairman, President & CEO, Director
Aug 3, 2026Buy+186,240$48.33$9.00M1,590,024
David C. Habiger
Director
Aug 3, 2026Buy+1,042$48.07$50.09K14,920
Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
Jul 31, 2026Discretionary+64,198$46.73$3.00M64,198
Edward J. Ludwig
Director
Jul 31, 2026Buy+5,000$45.48$227.40K30,359
Jonathan Monson
EVP and CFO
Jul 1, 2026Tax withholding−1,010$43.06$43.49K39,063
Jonathan Monson
EVP and CFO
Jul 1, 2026Option exercise+2,087––40,073
Michael F. Mahoney
Chairman, President & CEO, Director
May 28, 2026Gift−386,755––0
Cheryl Pegus
Director
May 20, 2026Buy+1,770$56.49$99.99K1,770
David C. Habiger
Director
May 20, 2026Buy+2,250$55.92$125.82K13,878
Edward J. Ludwig
Director
May 20, 2026Buy+3,580$56.68$202.91K25,359
David C. Habiger
Director
May 19, 2026Buy+2,200$56.95$125.29K11,628
Edward J. Ludwig
Director
May 7, 2026Award+3,800––21,779
Christophe Pierre Weber
Director
May 7, 2026Award+1,767––2,646
Christophe Pierre Weber
Director
May 7, 2026Award+1,140––3,786
Susan E. Morano
Director
May 7, 2026Award+3,800––10,463
Susan E. Morano
Director
May 7, 2026Award+1,281––11,744
Ellen M. Zane
Director
May 7, 2026Award+3,800––27,934
Jessica L. Mega
Director
May 7, 2026Award+3,800––12,035
David S. Wichmann
Director
May 7, 2026Award+3,800––45,382
David C. Habiger
Director
May 7, 2026Award+3,800––9,428
Arthur C. Butcher
EVP& Grp Pres, MedSurg & APAC
May 2, 2026Option exercise+2,102––57,894
Arthur C. Butcher
EVP& Grp Pres, MedSurg & APAC
May 2, 2026Tax withholding−1,007$56.50$56.90K56,887
Padraig Andrew O'Connor
EVP, Global Operations
May 2, 2026Option exercise+1,802––7,896
Padraig Andrew O'Connor
EVP, Global Operations
May 2, 2026Tax withholding−872$56.50$49.27K7,024
Christophe Pierre Weber
Director
Mar 2, 2026Award+323––879
Christophe Pierre Weber
Director
Mar 2, 2026Award+556––556
Susan E. Morano
Director
Mar 2, 2026Award+24––6,663
Emily Woodworth
SVP, Global Controller and CAO
Mar 1, 2026Tax withholding−372$76.85$28.59K2,859
Emily Woodworth
SVP, Global Controller and CAO
Mar 1, 2026Option exercise+838––3,231
Arthur C. Butcher
EVP& Grp Pres, MedSurg & APAC
Feb 19, 2026Discretionary+6,851$75.76$519.03K20,205
Miriam O'Sullivan
SVP, Chief HR Officer
Feb 16, 2026Option exercise+990––17,593
Miriam O'Sullivan
SVP, Chief HR Officer
Feb 16, 2026Tax withholding−291$74.73$21.75K17,302
Padraig Andrew O'Connor
EVP, Global Operations
Feb 16, 2026Option exercise+905––6,433
Padraig Andrew O'Connor
EVP, Global Operations
Feb 16, 2026Tax withholding−339$74.73$25.33K6,094
Emily Woodworth
SVP, Global Controller and CAO
Feb 16, 2026Tax withholding−283$74.73$21.15K2,393
Emily Woodworth
SVP, Global Controller and CAO
Feb 16, 2026Option exercise+637––2,676
Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
Feb 16, 2026Option exercise+3,960––215,713
Joseph Michael Fitzgerald
EVP & Group Pres, Cardiology
Feb 16, 2026Tax withholding−1,806$74.73$134.96K213,907
Jonathan Monson
EVP and CFO
Feb 16, 2026Option exercise+990––38,426
Jonathan Monson
EVP and CFO
Feb 16, 2026Tax withholding−440$74.73$32.88K37,986
Michael F. Mahoney
Chairman, President & CEO, Director
Feb 16, 2026Tax withholding−7,865$74.73$587.75K1,576,860
Michael F. Mahoney
Chairman, President & CEO, Director
Feb 16, 2026Option exercise+16,265––1,584,725
Vance R. Brown
EVP, GC and Corp. Secretary
Feb 16, 2026Option exercise+1,839––55,134
Vance R. Brown
EVP, GC and Corp. Secretary
Feb 16, 2026Tax withholding−890$74.73$66.51K54,244
Arthur C. Butcher
EVP& Grp Pres, MedSurg & APAC
Feb 16, 2026Tax withholding−1,229$74.73$91.84K55,792
Arthur C. Butcher
EVP& Grp Pres, MedSurg & APAC
Feb 16, 2026Option exercise+2,546––57,021
Miriam O'Sullivan
SVP, Chief HR Officer
Feb 14, 2026Option exercise+1,124––16,932
Miriam O'Sullivan
SVP, Chief HR Officer
Feb 14, 2026Tax withholding−329$74.73$24.59K16,603

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
2.43%
35M shares short
Days to cover
1.6
At 21M shares a day
Change since last report
-13.7%
From 41M shares
Short volume, 20 days
35.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Boston Scientific's stock actually held short. Settlement fails (shares not delivered on time) peaked at 28,890 shares on Aug 20, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Michael F. Mahoney
Officer, Director
Feb 2, 2026160,901$15.04MFeb 2, 2026Performance Shares
Arthur C. Butcher
Officer
Dec 1, 202517,313$1.76MDec 1, 2025Stock Option Exercise
Ellen M. Zane
Director
Nov 6, 20252,901$284.17KNov 6, 2025stock grant
Joseph Michael Fitzgerald
Officer
Nov 3, 202550,000$4.97MNov 3, 2025Stock Option Exercise
Ellen M. Zane
Director
Oct 28, 20252,901$296.59KOct 28, 2025Stock Grant
Ellen M. Zane
Director
Oct 27, 20259,990$1.01MOct 27, 2025Stock Grant
Joseph Michael Fitzgerald
Officer
Oct 1, 202550,000$4.92MOct 1, 2025Stock Option Exercise
Joseph Michael Fitzgerald
Officer
Sep 2, 202550,000$5.27MSep 2, 2025Stock Option Exercise
Joseph Michael Fitzgerald
Officer
Aug 1, 202550,000$5.23MAug 1, 2025Stock Option Exercise
Arthur C. Butcher
Officer
Aug 1, 202517,313$1.81MAug 1, 2025Stock Option Exercise
Yoshiaki Fujimori
Director
Jul 29, 20252,901$310.38KJul 29, 2025Restricted Stock
Edward J. Ludwig
Director
Jul 25, 20254,000$429.84KJul 25, 2025RSU Granted Shares
Joseph Michael Fitzgerald
Officer
Jul 1, 202550,000$5.35MJul 1, 2025Stock Option Exercise
Joseph Michael Fitzgerald
Officer
Jun 4, 202556,372$5.80MJun 4, 2025Stock Option Exercise
Michael F. Mahoney
Officer, Director
Jun 2, 2025164,443$17.05MJun 2, 2025Restricted Stock

Congress trades

40 trades in Boston Scientific reported by 9 members of the House

MemberTypeTradedAmountFiled
Kevin Hern
OK01 · joint account
SoldSep 9, 2026$50K–100KSep 25, 2026
Kevin Hern
OK01 · joint account
Sold (part)Sep 4, 2026$50K–100KSep 25, 2026
Kevin Hern
OK01 · child
SoldSep 3, 2026$1K–15KSep 25, 2026
Kevin Hern
OK01 · child
SoldSep 3, 2026$1K–15KSep 25, 2026
Kevin Hern
OK01 · child
SoldSep 3, 2026$1K–15KSep 25, 2026
Kevin Hern
OK01 · joint account
SoldAug 31, 2026$15K–50KSep 25, 2026
Gilbert Cisneros
CA31
BoughtAug 18, 2026$1K–15KSep 10, 2026
Rohit Khanna
CA17 · child
BoughtAug 10, 2026$1K–15KSep 4, 2026
Gilbert Cisneros
CA31
Sold (part)Jun 5, 2026$1K–15KJul 2, 2026
Gilbert Cisneros
CA31
BoughtJun 5, 2026$1K–15KJul 2, 2026
Gilbert Cisneros
CA31
BoughtMay 29, 2026$1K–15KJun 8, 2026
Gilbert Cisneros
CA31
BoughtMay 19, 2026$1K–15KJun 8, 2026
Gilbert Cisneros
CA31
BoughtMay 11, 2026$1K–15KJun 8, 2026
Rohit Khanna
CA17 · child
BoughtMar 30, 2026$15K–50KApr 7, 2026
Gilbert Cisneros
CA31
BoughtFeb 10, 2026$1K–15KMar 9, 2026
Gilbert Cisneros
CA31
BoughtJan 30, 2026$1K–15KFeb 13, 2026
Gilbert Cisneros
CA31
Sold (part)Dec 24, 2025$1K–15KJan 12, 2026
Gilbert Cisneros
CA31
BoughtNov 18, 2025$1K–15KDec 15, 2025
Lisa McClain
MI09 · spouse
SoldOct 31, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
BoughtOct 30, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
SoldOct 30, 2025$1K–15KNov 21, 2025
Kevin Hern
OK01 · joint account
Sold (part)Oct 28, 2025$15K–50KNov 16, 2025
Gilbert Cisneros
CA31
BoughtOct 17, 2025$1K–15KNov 18, 2025
Valerie Hoyle
OR04 · spouse
SoldSep 23, 2025$1K–15KOct 10, 2025
Lisa McClain
MI09 · spouse
Sold (part)Aug 4, 2025$1K–15KSep 12, 2025
Gilbert Cisneros
CA31
Sold (part)Jul 31, 2025$1K–15KAug 14, 2025
Gilbert Cisneros
CA31
Sold (part)Jun 26, 2025$1K–15KJul 10, 2025
Gilbert Cisneros
CA31
Sold (part)Jun 11, 2025$1K–15KJul 10, 2025
Gilbert Cisneros
CA31
Sold (part)May 13, 2025$1K–15KJun 6, 2025
Jefferson Shreve
IN06
SoldMay 12, 2025$15K–50KJun 22, 2025
Gilbert Cisneros
CA31
Sold (part)Apr 28, 2025$1K–15KMay 6, 2025
Bruce Westerman
AR04
SoldApr 21, 2025$1K–15KMay 12, 2025
Gilbert Cisneros
CA31
Sold (part)Mar 17, 2025$1K–15KApr 7, 2025
Bruce Westerman
AR04
BoughtMar 3, 2025$1K–15KApr 16, 2025
Gilbert Cisneros
CA31
Sold (part)Feb 24, 2025$1K–15KMar 6, 2025
Lisa McClain
MI09 · spouse
BoughtDec 11, 2024$1K–15KAug 13, 2025
245 days late
Valerie Hoyle
OR04 · spouse
BoughtOct 29, 2024$1K–15KSep 12, 2025
318 days late
Rohit Khanna
CA17 · child
BoughtDec 5, 2023$1K–15KJan 4, 2024
John Curtis
UT03 · joint account
SoldDec 4, 2023$1K–15KDec 15, 2023
Lois Frankel
FL22
SoldSep 8, 2023$1K–15KOct 10, 2023

See a number that looks wrong?